February 28, 2015 7:52 PM ET

Capital Markets

Company Overview of JLL Partners

Company Overview

JLL Partners is a private equity firm specializing in investments in middle market companies. The firm prefers to invest in balance sheet restructurings, debt financing, buyouts, recapitalization, corporate divestitures, operational turnarounds, acquisitions, bolt-on acquisitions, add-on acquisitions, industry consolidations, and strategic co-investments. It invests in companies which are significantly over-leveraged; companies lacking committed sponsorship; companies requiring strategic and/or operational refocusing; companies in out-of-favor industries; businesses being divested from a larger corporate entity; and companies seeking a financial partner to pursue their strategies. The firm s...

450 Lexington Avenue

31st floor

New York, NY 10017

United States

Founded in 1988





Key Executives for JLL Partners

Co-Founder, Managing Director, and Managing Partner
Age: 67
Chief Financial Officer
Managing Director, Head of Investor Relations
Managing Director and member of Investment Committee
Age: 41
Managing Director and Member of Investment Committee
Age: 64
Compensation as of Fiscal Year 2014.

JLL Partners Key Developments

JLL Partners, Inc Partners to Form Joint Venture with Royal DSM N.V

JLL Partners Inc. has agreed to form a joint venture with Royal DSM N.V. The new company (NewCo), which will be 51% owned by JLL and 49% by DSM, will be a contract development and manufacturing organization (CDMO) for the pharmaceutical industry. NewCo will be formed by combining DSM's business group DSM Pharmaceutical Products (DPP) with JLL's portfolio company Patheon Inc. NewCo will operate as an independent standalone company with about 8,300 employees. JLL will contribute $489 million in cash to NewCo, and DSM will contribute DSM Pharmaceutical Products (DPP) and receive a seller note of $200 million, thereby valuing DPP at $670 million. NewCo has entered into a definitive agreement to effect a plan of arrangement pursuant to the Canada Business Corporations Act (POA) with Patheon under which NewCo would acquire Patheon for $9.32 per share in cash resulting in; a total enterprise value for Patheon of approximately $1,950 million; 64% premium to Patheon's closing share price on November 18, 2013. The transaction is expected to close in first half of 2014.

Similar Private Companies By Industry

Company Name Region
De Bellas & Co. United States
Jefferies High Yield Finance, LLC United States
M.J. Whitman LLC United States
Middle Market Capital, LLC United States
Rosewood Property Co United States

Recent Private Companies Transactions

January 6, 2015
Pioneer Sand Company, Inc. and Pioneer Landscaping Materials, Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JLL Partners, please visit www.jllpartners.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.